SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001159036-19-000013
Filing Date
2019-03-22
Accepted
2019-03-22 16:07:48
Documents
8
Period of Report
2018-12-31
Effectiveness Date
2019-03-22

Document Format Files

Seq Description Document Type Size
1 DEF 14A PROXY halodefproxy2019.htm DEF 14A 911547
2 halologobwa05.jpg GRAPHIC 38428
3 htsignaturea06.jpg GRAPHIC 31598
4 leonhardtsignature2a05.jpg GRAPHIC 413112
5 slide1a81.jpg GRAPHIC 52580
6 slide1a82.jpg GRAPHIC 54260
7 slide2a66.jpg GRAPHIC 56638
8 slide4a27.jpg GRAPHIC 57982
  Complete submission text file 0001159036-19-000013.txt   1846156
Mailing Address 11388 SORRENTO VALLEY ROAD SAN DIEGO CA 92121-1345
Business Address 11388 SORRENTO VALLEY ROAD SAN DIEGO CA 92121-1345 (858) 794-8889
HALOZYME THERAPEUTICS INC (Filer) CIK: 0001159036 (see all company filings)

IRS No.: 880488686 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-32335 | Film No.: 19699910
SIC: 2836 Biological Products, (No Diagnostic Substances)